BioInvent Announces Updated Phase 2a Triple Combination Arm Data of BI-1206, rituximab, and Calquence for the Treatment of Non-Hodgkin's Lymphoma
Latest preliminary data show continued promising clinical activity in NHL patients, with two complete responses (CR), three partial responses (PR), and three stable disease (SD) as best clinical response in the first eight patients evaluated
Results equate to an objective response rate (CRs and PRs) of 63%
Data from an earlier cutoff date in February are included in an abstract published today by the European Hematology Association (EHA) 2025 conference
LUND, SE / / May 14, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today announces latest updated data from the ongoing Phase 2a study of BI-1206 in combination with rituximab and Calquence® (acalabrutinib) for the treatment of non-Hodgkin's lymphoma (NHL). Additionally today, an abstract containing data from an earlier February cutoff date has been published by the European Hematology Association (EHA) as part of its 2025 congress due to take place June 12-15 in Milan, Italy.
The data released today show the first eight patients in the triple combination arm of BioInvent's ongoing Phase 2a in non-Hodgkin's lymphoma. All patients exhibited disease control at first assessment (DCR 100%), and results show an overall objective response rate of 63% with two patients achieving a complete response (CR) and three patients with partial responses (PR). Stable disease (SD) was observed in the three remaining patients. The combination has been well tolerated in all patients treated at the cut-off-date. These data are further updated compared to the data included in the EHA abstract.
"We continue to be encouraged by the early data demonstrating robust clinical activity and manageable safety profile in the ongoing triple combination arm of the Phase 2a study of BI-1206 in combination with rituximab and Calquence in NHL patients who have relapsed after previous lines of treatment," said Martin Welschof, Chief Executive Officer of BioInvent. "The objective responses observed to date highlight the potential of the combination to improve outcomes and overcome resistance, a result we believe is driven by the mechanism of action of BI-1206. Previously we have demonstrated that BI-1206 can restore response to rituximab in relapsed/refractory patients. Now we demonstrate that a BTK inhibitor may be added to this combination without compromising safety. We look forward to advancing the clinical development of this promising and highly convenient treatment."
Details of the EHA abstract released today are below:
Title: BI-1206, an Antibody Targeting FcγRIIB, given in Combination with Rituximab and Acalabrutinib in Subjects with Indolent B-Cell Non-Hodgkin's LymphomaLead Author: Laura Fogliatto, Hospital de Clínicas de Porto Alegre, Porto Alegre, BrazilAbstract Number: PB3180
About the studyThe triple combination arm in the ongoing Phase 2a study combines the subcutaneous formulation of BI-1206 and rituximab with Calquence® (acalabrutinib) in subjects with indolent B-cell non-Hodgkin's lymphoma (NHL) relapsed or refractory to rituximab. Approximately 30 patients are expected to be enrolled in Spain, Germany, the US, and Brazil. In February 2024 BioInvent signed a clinical supply agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) to provide Calquence® for the combination arm.
About BI-1206BI-1206 is one of BioInvent's lead drug candidates and is developed to re-establish the clinical effect of existing cancer treatments such as pembrolizumab and rituximab. The drug candidate is evaluated in two separate clinical programs, one for the treatment of non-Hodgkin's lymphoma (NHL, a type of blood cancer) and one for the treatment of solid tumors.
About BioInventBioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently five drug candidates in six ongoing clinical programs in Phase 1/2 trials for the treatment of hematological cancer and solid tumors. The Company's validated, proprietary F.I.R.S.T™ technology platform identifies both targets and the antibodies that bind to them, generating many promising new immune-modulatory candidates to fuel the Company's own clinical development pipeline and providing licensing and partnering opportunities.
The Company generates revenues from research collaborations and license agreements with multiple top-tier pharmaceutical companies, as well as from producing antibodies for third parties in the Company's fully integrated manufacturing unit. More information is available at www.bioinvent.com.
For further information, please contact:Cecilia Hofvander, VP Investor RelationsPhone: +46 (0)46 286 85 50Email: cecilia.hofvander@bioinvent.com
BioInvent International AB (publ)Co. Reg. No.: 556537-7263Visiting address: Ideongatan 1Mailing address: 223 70 LUNDPhone: +46 (0)46 286 85 50www.bioinvent.com
The press release contains statements about the future, consisting of subjective assumptions and forecasts for future scenarios. Predictions for the future only apply as the date they are made and are, by their very nature, in the same way as research and development work in the biotech segment, associated with risk and uncertainty. With this in mind, the actual outcome may deviate significantly from the scenarios described in this press release.
This information is information that BioInvent International is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-05-14 15:30 CEST.
Attachments
BioInvent Announces Updated Phase 2a Triple Combination Arm Data of BI-1206, rituximab, and Calquence for the treatment of non-Hodgkin's lymphoma
SOURCE: BioInvent International
View the original press release on ACCESS Newswire
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Business Insider
an hour ago
- Business Insider
The future of AI will be governed by protocols no one has agreed on yet
The tech industry, much like everything else in the world, abides by certain rules. With the boom in personal computing came USB, a standard for transferring data between devices. With the rise of the internet came IP addresses, numerical labels that identify every device online. With the advent of email came SMTP, a framework for routing email across the internet. These are protocols — the invisible scaffolding of the digital realm — and with every technological shift, new ones emerge to govern how things communicate, interact, and operate. As the world enters an era shaped by AI, it will need to draw up new ones. But AI goes beyond the usual parameters of screens and code. It forces developers to rethink fundamental questions about how technological systems interact across the virtual and physical worlds. How will humans and AI coexist? How will AI systems engage with each other? And how will we define the protocols that manage a new age of intelligent systems? Across the industry, startups and tech giants alike are busy developing protocols to answer these questions. Some govern the present in which humans still largely control AI models. Others are building for a future in which AI has taken over a significant share of human labor. "Protocols are going to be this kind of standardized way of processing non-deterministic information," Antoni Gmitruk, the chief technology officer of Golf, which helps clients deploy remote servers aligned with Anthropic's Model Context Protocol, told BI. Agents, and AI in general, are "inherently non-deterministic in terms of what they do and how they behave." When AI behavior is difficult to predict, the best response is to imagine possibilities and test them through hypothetical scenarios. Here are a few that call for clear protocols. Scenario 1: Humans and AI, a dialogue of equals Games are one way to determine which protocols strike the right balance of power between AI and humans. In late 2024, a group of young cryptography experts launched Freysa, an AI agent that invites human users to manipulate it. The rules are unconventional: Make Freysa fall in love with you or agree to concede its funds, and the prize is yours. The prize pool grows with each failed attempt in a standoff between human intuition and machine logic. Freysa has caught the attention of big names in the tech industry, from Elon Musk, who called one of its games "interesting," to veteran venture capitalist Marc Andreessen. "The core technical thing we've done is enabled her to have her own private keys inside a trusted enclave," said one of the architects of Freysa, who spoke under the condition of anonymity to BI in a January interview. Secure enclaves are not new in the tech industry. They're used by companies from AWS to Microsoft as an extra layer of security to isolate sensitive data. In Freysa's case, the architect said they represent the first step toward creating a "sovereign agent." He defined that as an agent that can control its own private keys, access money, and evolve autonomously — the type of agent that will likely become ubiquitous. "Why are we doing it at this time? We're entering a phase where AI is getting just good enough that you can see the future, which is AI basically replacing your work, my work, all our work, and becoming economically productive as autonomous entities," the architect said. In this phase, they said Freysa helps answer a core question: "What does human involvement look like? And how do you have human co-governance over agents at scale?" In May, the The Block, a crypto news site, revealed that the company behind Freysa is Eternis AI. Eternis AI describes itself as an "applied AI lab focused on enabling digital twins for everyone, multi-agent coordination, and sovereign agent systems." The company has raised $30 million from investors, including Coinbase Ventures. Its co-founders are Srikar Varadaraj, Pratyush Ranjan Tiwari, Ken Li, and Augustinas Malinauskas. Scenario 2: To the current architects of intelligence Freysa establishes protocols in anticipation of a hypothetical future when humans and AI agents interact with similar levels of autonomy. The world, however, needs also to set rules for the present, where AI still remains a product of human design and intention. AI typically runs on the web and builds on existing protocols developed long before it, explained Davi Ottenheimer, a cybersecurity strategist who studies the intersection of technology, ethics, and human behavior, and is president of security consultancy flyingpenguin. "But it adds in this new element of intelligence, which is reasoning," he said, and we don't yet have protocols for reasoning. "I'm seeing this sort of hinted at in all of the news. Oh, they scanned every book that's ever been written and never asked if they could. Well, there was no protocol that said you can't scan that, right?" he said. There might not be protocols, but there are laws. OpenAI is facing a copyright lawsuit from the Authors Guild for training its models on data from "more than 100,000 published books" and then deleting the datasets. Meta considered buying the publishing house Simon & Schuster outright to gain access to published books. Tech giants have also resorted to tapping almost all of the consumer data available online from the content of public Google Docs and the relics of social media sites like Myspace and Friendster to train their AI models. Ottenheimer compared the current dash for data to the creation of ImageNet — the visual database that propelled computer vision, built by Mechanical Turk workers who scoured the internet for content. "They did a bunch of stuff that a protocol would have eliminated," he said. Scenario 3: How to take to each other As we move closer to a future where artificial general intelligence is a reality, we'll need protocols for how intelligent systems — from foundation models to agents — communicate with each other and the broader world. The leading AI companies have already launched new ones to pave the way. Anthropic, the maker of Claude, launched the Model Context Protocol, or MCP, in November 2024. It describes it as a "universal, open standard for connecting AI systems with data sources, replacing fragmented integrations with a single protocol." In April, Google launched Agent2Agent, a protocol that will "allow AI agents to communicate with each other, securely exchange information, and coordinate actions on top of various enterprise platforms or applications." These build on existing AI protocols, but address new challenges of scaling and interoperability that have become critical to AI adoption. So, managing their behavior is the "middle step before we unleash the full power of AGI and let them run around the world freely," he said. When we arrive at that point, Gmitruk said agents will no longer communicate through APIs but in natural language. They'll have unique identities, jobs even, and need to be verified. "How do we enable agents to communicate between each other, and not just being computer programs running somewhere on the server, but actually being some sort of existing entity that has its history, that has its kind of goals," Gmitruk said. It's still early to set standards for agent-to-agent communication, Gmitruk said. Earlier this year he and his team initially launched a company focused on building an authentication protocol for agents, but pivoted. "It was too early for agent-to-agent authentication," he told BI over LinkedIn. "Our overall vision is still the same -> there needs to be agent-native access to the conventional internet, but we just doubled down on MCP as this is more relevant at the stage of agents we're at." Does everything need a protocol? Definitely not. The AI boom marks a turning point, reviving debates over how knowledge is shared and monetized. McKinsey & Company calls it an "inflection point" in the fourth industrial revolution — a wave of change that it says began in the mid-2010s and spans the current era of "connectivity, advanced analytics, automation, and advanced-manufacturing technology." Moments like this raise a key question: How much innovation belongs to the public and how much to the market? Nowhere is that clearer than in the AI world's debate between the value of open-source and closed models. "I think we will see a lot of new protocols in the age of AI," Tiago Sada, the chief product officer at Tools for Humanity, the company building the technology behind Sam Altman's World. However, "I don't think everything should be a protocol." World is a protocol designed for a future in which humans will need to verify their identity at every turn. Sada said the goal of any protocol "should be like this open thing, like this open infrastructure that anyone can use," and is free from censorship or influence. At the same time, "one of the downsides of protocols is that they're sometimes slower to move," he said. "When's the last time email got a new feature? Or the internet? Protocols are open and inclusive, but they can be harder to monetize and innovate on," he said. "So in AI, yes — we'll see some things built as protocols, but a lot will still just be products."


Miami Herald
an hour ago
- Miami Herald
The NHL's Sharks, Ducks And Blue Jackets Could Prove Disruptive In 2025 Free Agency
On July 1, the NHL will celebrate the 20th anniversary of the introduction of the salary cap with the largest single-year jump in the cap's history. But for players, free agency isn't just about money: it's also about opportunity. And while the three teams that are currently hoarding the most available cap space heading into July 1 haven't been big players in recent years, that could change in 2025 - even in the face of stiff competition. According to PuckPedia, the San Jose Sharks are headed into free agency with the most projected cap space: $41.76 million. The Columbus Blue Jackets are second at $40.4 million, and the Anaheim Ducks are third at $38.69 million. All three are ready to take the next step, so don't be surprised if they take some big swings on July 1 - whether that's in free agency or through blockbuster trades. In San Jose, the Sharks are heading into Year 4 of the Mike Grier regime. After bottoming out and successfully snagging Macklin Celebrini in 2024, San Jose still finished 32nd overall last season. But Celebrini and Will Smith showed strong signs that they'll be foundational players, as did goalie-of-the-future Yaroslav Askarov. There's also more promising young talent in the pipeline. In his rookie year as an NHL head coach, Ryan Warsofsky also showed a deft hand in managing his players. He added a feather to his cap by guiding Team USA to its first gold medal since 1933 at the world championship. And while Warsofsky may be new on the scene, he has the qualities of a coach who inspires player loyalty. At the 2025 trade deadline, Grier performed major surgery again. That leaves plenty of roster spots open for players who are looking to make a difference with an emerging squad. Compared to the last few years, San Jose is on the rise as a signing destination. In Anaheim, the Ducks became a more desirable destination by replacing taskmaster Greg Cronin with Joel Quenneville behind the bench. Though he has been out of the game since 2021, Quenneville's record speaks for itself: on top of his four Stanley Cups, he has more wins on his resume than any NHL coach not named Scotty Bowman. Quenneville also has a reputation as the kind of coach that players love to play for. While that should be attractive to free agents in general, could it also be a carrot for a couple of future Hall of Famers who played their best hockey under Quenneville with the Chicago Blackhawks? After two years out of the game himself, Jonathan Toews has made it clear that he's ready to attempt a comeback this fall. It will be odd to see him wearing anything other than Chicago colors, but a reunion with his old bench boss could make sense. And while it's tempting to presume that Toews won't be a high-impact player at age 37, the current playoff exploits of similarly aged Brad Marchand and Corey Perry would suggest otherwise. Gabriel Landeskog and Evander Kane have also recently demonstrated that it's possible to return at a high level after long absences from top-level competition. If Toews chose to reunite with Quenneville, could Patrick Kane also head west? After going through health issues of his own, Kane is a pending free agent coming off back-to-back 20-goal seasons with the Detroit Red Wings, who haven't quite found a way to get back into the playoff mix. Toews and Kane won three Stanley Cups together in Chicago, were represented by the same agent, and played under matching contracts as the Blackhawks' top stars. If the pair reunited in Orange County, would other free agents be tempted to come along for the ride? In Columbus, the Blue Jackets knocked at the door of a playoff spot this spring, finishing two points behind the Montreal Canadiens in the Eastern Conference standings. It was an impressive achievement for a new regime led by GM Don Waddell and coach Dean Evason, especially in the wake of the unexpected tragedy of Johnny and Matthew Gaudreau's deaths. Gaudreau, of course, defied expectations in 2022, when he chose Columbus as one of that summer's top free agents. His longtime buddy Sean Monahan joined him last year and became such a pillar of strength in supporting his team and honoring his friend's legacy that he was voted the 2025 winner of the Masterton Trophy. Any player who signs with Columbus will know that they're walking into a dressing room where players truly have each other's backs. They'll also be walking onto a roster that features 2025 Norris Trophy finalist Zach Werenski and a strong group of emerging talents, many of whom had career years in 2024-25. Get the latest news and trending stories by following The Hockey News on Google News and by subscribing to The Hockey News newsletter here. And share your thoughts by commenting below the article on Copyright The Hockey News, Roustan Media Ltd.

Business Insider
8 hours ago
- Business Insider
American tourists can't quite quit Europe
The American dream may be struggling, but for many, the Euro summer dream is alive and well. Jimin Shim, a millennial copywriter who lives in Denver, has plenty of concerns about the economy, from stock market volatility that she feels has been brought on by the current administration to a tough job market. Still, she's vacationing in Portugal later this month, and treating her mom to the trip too. "Traveling is very important to me. I try to do at least one international trip a year and then maybe a couple of domestic trips," she told Business Insider. "And because I know that that is a priority for me, it's something that I budget for and am saving up for all year round." While there's been some softening in leisure travel demand this year, data and surveys suggest Shim is one of many Americans who are weighing their international travel plans against their worries about the economy and saying, "book it." The extent to which Americans are pulling back on international trips this summer is not fully clear. An analysis from Cirium, an aviation analytics company, found summer bookings from the US to Europe were down nearly 10% from January to May compared to last year. Meanwhile, a summer travel survey from Deloitte, released in May, found more Americans were traveling internationally this summer compared to 2024, with most headed to Europe. And a recent data analysis by Allianz Partners, a travel insurance and assistance company, found summer travel from the US to Europe would increase by 10% in 2025. The economy isn't the only reason Americans might rethink travel to Europe this summer. The weakening US dollar doesn't go as far as it used to, and some Americans are worried about their safety or not feeling welcomed abroad due to the current administration's approach to foreign policy. Americans are also waiting longer to book their trips, which could complicate the picture. Still, it's clear that many Americans are traveling abroad despite the downturn in consumer sentiment. "I think you're seeing a hesitancy," Amir Eylon, president and CEO of Longwoods International, a market research consultancy that specializes in the travel tourism industry, told BI. "I still believe a majority of American travelers who were planning to go abroad are still going to go abroad." The enduring appeal of Euro summer Eylon said that while there are indications of a slowdown, it does not look like a "game-changing" shift. His firm's monthly consumer sentiment survey of 1,000 travelers found the number of American travelers who said they were very likely to take an international trip in the next 12 months declined from 25% in January to 19% in May. He noted travelers seemed to be in a "wait and see" mode this spring, echoing what other industry experts have said and previously told BI — that travelers are booking closer to travel dates, in part as they search for good deals. Eylon said it is possible there will be an overall decline in Americans visiting Europe this year, but it's too soon to tell the full picture. He thinks those canceling or ditching trip plans will be in the minority. "American travelers view it as a need more than a want," he said of travel, adding that many see it as a "right." Meredith Pierce, a travel content creator based in Atlanta, said that's exactly how she and many other millennials and Gen Zers view travel, including to Europe. Pierce posts a lot of popular "Euro summer" content and sees it as a persistent and lasting travel trend, even when folks have financial concerns. "Everyone loves the idea of sipping an Aperol spritz and looking at the Mediterranean," Pierce said, "especially if maybe you are stressed in your day-to-day life because of politics or the economy or budgets, or anything like that. A bit of escapism I think comes into play there as well." The hesitancy fueled by economic uncertainty could also make it a bit more affordable to travel to Europe this summer. Eylon noted the slowdown in leisure travel led to some declines in airfare prices, which may have pushed some hesitant Americans to take the plunge. When economic concerns, largely fueled by Trump's tariff policy, intensified in March and April, some airlines suspended their forecasts for the year, and flight prices declined. Rather than get spooked by the economic uncertainty, Pierce believes plenty of people pounced. Her "Euro summer" content from last year started going viral, and she was getting flooded with DMs and questions from people who found a cheap flight to Europe and were suddenly planning their trips. Pierce said some budget-conscious travelers are opting for more affordable and under-the-radar destinations in Europe, such as Albania or Poland, which feature similarly picturesque scenes but at a lower cost than Italy or Paris. More frugal spending once they get to their destination Deloitte's summer travel survey noted that many American travelers already had their big summer trips partially or even fully booked by April, when concerns around tariffs and the economy intensified. The survey also found that while consumers' sense of financial well-being was down year-over-year in April, slightly more Americans planned to take leisure vacations this summer compared to 2024. Deloitte found travelers looking to save were cutting back on in-destination spending as well as opting for more affordable lodging and flight classes. The survey also found that while some are being more frugal, many Americans are prioritizing bucket list trips and international travel, or trips that are otherwise special in some way. Deloitte found 42% of air travelers were flying internationally on their longest summer trip, compared to 38% in 2024. Those traveling internationally were also more likely to increase their travel budget compared to last year. Shim, the copywriter from Denver, also has a special reason for making her Portugal trip work this year, despite her financial concerns. Her family has been going through a tough time after her grandfather's death last year. This vacation is a way to spend quality time with and treat her mom, who has never been to Europe, and take the first trip that's just the two of them. "I also think that sometimes in these times of uncertainty and tumultuousness and a lot of tension and division, traveling and spending quality time with family who loves you is a great way to just take care of your mental and emotional health too," she said, "which I think is also very important to do."